Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Northern Trust Corporation Common Stock (NTRS) Price & Performance

Ionis Pharmaceuticals Inc. Common StockTrade
Northern Trust Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Ionis Pharmaceuticals Inc. Common Stock vs Northern Trust Corporation Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B), while Northern Trust Corporation Common Stock trades at $162.48 (market cap $29.76B). The key difference: Northern Trust Corporation Common Stock is far larger — about 4.2× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Northern Trust Corporation Common Stock pays a 2.02% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Northern Trust Corporation Common Stock for 0 Days on average.

IONSNTRS
Market Cap
$7.10B$29.76B
Volume
2,027,4571,427,762
Sector
HealthFinancials
52-Week High
$86.50$191.47
52-Week Low
$42.38$122.72
Typical Hold Time
0 Days0 Days
Enterprise Value
$6.66B-$6.24B
Dividend Yield
—2.02%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IONS
100% Buy0% Sell
Avg holding period · 0 Days
NTRS
100% Buy0% Sell
Avg holding period · 0 Days

About Ionis Pharmaceuticals Inc. Common Stock

Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.

Read more on IONS →

About Northern Trust Corporation Common Stock

Northern Trust Corporation is a financial holding company that provides asset servicing, asset management, wealth management, and banking services through its Asset Servicing and Wealth Management segments. It serves corporations, institutions, and affluent individuals across US and international markets.

Read more on NTRS →